Altered expression of cytokines in mice infected intranasally with two syncytial variants of Herpes simplex virus type 1 by Artuso, María Carolina et al.
Accepted Manuscript
Altered expression of cytokines in mice infected intranasally with two syncytial
variants of Herpes simplex virus type 1
M. Carolina Artuso, Florencia N. Linero, Silvina Gazzaniga, Luis A. Scolaro, Carlos A.
Pujol, Rosa Wainstok, M. Josefina Carlucci, PhD.
PII: S0882-4010(14)00055-2
DOI: 10.1016/j.micpath.2014.04.004
Reference: YMPAT 1485
To appear in: Microbial Pathogenesis
Received Date: 28 August 2013
Revised Date: 11 April 2014
Accepted Date: 15 April 2014
Please cite this article as: Artuso MC, Linero FN, Gazzaniga S, Scolaro LA, Pujol CA, Wainstok R,
Carlucci MJ, Altered expression of cytokines in mice infected intranasally with two syncytial variants of
Herpes simplex virus type 1, Microbial Pathogenesis (2014), doi: 10.1016/j.micpath.2014.04.004.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 1 
Altered expression of cytokines in mice infected intranasally with two syncytial 2 
variants of Herpes simplex virus type 1  3 
 4 
 5 
 6 
Keywords:  herpes, virulence, cytokines, pathology, mouse 7 
 8 
 9 
 10 
M. Carolina Artuso1,3, Florencia N. Linero1, Silvina Gazzaniga2,3, Luis A. Scolaro1, Carlos 11 
A. Pujol1,3, Rosa Wainstok2,3,  M. Josefina Carlucci1,3*. 12 
 13 
1Laboratorio de Virología- Departamento de Química Biológica,  2Laboratorio de Biología 14 
Tumoral- Departamento de Química Biológica, 3IQUIBICEN (CONICET-UBA),  Facultad 15 
de Ciencias Exactas y Naturales, Ciudad Universitaria, Pab.2, Piso 4. Ciudad Universitaria, 16 
1428EGA, Buenos Aires, Argentina.  17 
 18 
 19 
Corresponding authors:  * María J. Carlucci PhD.– Email: majoc@qb.fcen.uba.ar 20 
                                             Telephone: +54-11-4576-3334, Fax: +54-11-45763342 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
 29 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
Abstract 30 
 31 
Immune evasion strategies are important for the onset and the maintenance of viral 32 
infections. Many viruses have evolved mechanisms to counteract or suppress the host 33 
immune response. We have previously characterized two syncytial (syn) variants of Herpes 34 
simplex 1 (HSV-1) strain F, syn14-1 and syn17-2, obtained by selective pressure with a 35 
natural carrageenan. These variants showed a differential pathology in vaginal and 36 
respiratory mucosa infection in comparison with parental strain. In this paper we evaluated 37 
the modulation of immune response in respiratory mucosa by these HSV-1 variants. We 38 
observed altered levels of Tumor Necrosis Factor-α and Interleukin-6 in lungs of animals 39 
infected with the syn14-1 and syn17-2 variants compared with the parental strain. Also, we 40 
detected differences in the recruitment of immune cells to the lung in syn variants infected 41 
mice. Both variants exhibit one point mutation in the sequence of the gene of glycoprotein 42 
D detected in the ectodomain of syn14-1 and the cytoplasmic tail of syn17-2. Results 43 
obtained in the present study contribute to the characterization of HSV-1 syn variants and 44 
the participation of the cellular inflammatory response in viral pathogenesis.  45 
 46 
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Main text 48 
Herpes simplex virus type 1 (HSV-1) is a human pathogen that infects and replicates in 49 
epithelial cells of mucosal surfaces with the eventual establishment of latency in the ganglia 50 
of sensory neurons. Important roles in limiting spread and early virus replication have been 51 
ascribed to macrophages and natural killer cells (NK), which constitute the first line of 52 
innate defense [1-3]. As expected, HSV-1 has evolved several strategies to counteract the 53 
antiviral response by preventing the infected host to trigger a strong immune response and 54 
thus facilitating viral replication. Furthermore, it has been previously reported that HSV is 55 
able to suppress expression of proinflammatory cytokines by decreasing the stability of 56 
mRNAs [4]. Secretion of proinflammatory cytokines is essential in the first line defense 57 
against viruses [5, 6]. One of the macrophages-derived products that contribute to inhibit 58 
HSV replication is the proinflammatory cytokine TNF-α [7] that plays an important role on 59 
the early innate immune response. Furthermore, macrophages and other cell types rapidly 60 
produce IL-6 at local tissue sites after HSV-1 infection [8]. IL-6 is a cytokine with 61 
pleiotropic activities, including both proinflammatory and anti-inflammatory effects, that 62 
has been characterized to contribute to immune response to HSV-1. At the same time, anti-63 
inflammatory cytokines are immunoregulatory molecules that control the proinflammatory 64 
cytokine response to impair an excessive response [9, 10].  65 
Natural carrageenans are known to be potent and selective inhibitors of HSV-1 and HSV-2, 66 
affecting mainly the viral adsorption step [11]. As a result of a previous work we performed 67 
we found that the selective pressure with the µ/ν- carrageenan 1C3 allowed the isolation of 68 
two syncytial (syn) variants of HSV-1 F strain, syn14-1 and syn17-2 which showed an 69 
altered pathology in vaginal and respiratory mucosa infection [12]. In fact, intranasal 70 
infection of BALB/c mice with syn variants induced 100% mortality at 7 days post-71 
infection (p.i.) and a differential infiltration of leukocytes was observed by 72 
histopathological studies from lung mucosa. 73 
Although HSV-1 is not a common respiratory virus in human, it can cause several 74 
pathological conditions associated with the respiratory tract. In fact, herpetic respiratory 75 
infections have been reported not only in neonates and immunosuppressed patients [13, 14], 76 
but also in immunocompetent ones [15, 16]. Moreover, HSV-1 is able to penetrate the 77 
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basement membrane of human nasal respiratory mucosa and to replicate both in epithelium 78 
and the underlying lamina propria of this tissue [17].  79 
Based on these data, in the present work we wanted to deepen the study of the intranasal 80 
infection of mice with variants syn14-1 and syn17-2 towards a better understanding of the 81 
participation of the cellular inflammatory response in the pathogenicity of these viruses. 82 
Taken into account the relevance of a rapid secretion of cytokines to counteract viral 83 
infections, we focused on the analysis of cytokine modulation in lungs of infected mice. To 84 
this end, BALB/c mice were infected with 106 PFU of syn14-1, syn17-2 or HSV-1 F strain, 85 
as a control. At day 1 and 3 p.i., bronchioalveolar lavages (BAL) were performed using 1 86 
ml of sterile saline solution. TNF-α, IL-6 and IL-10 levels were studied by ELISA 87 
according to manufacturer´s instructions (BD Biosciences) and virus yield was quantified 88 
by plaque assay. Animals were maintained and handled in accordance with national and 89 
international laws and policies from National Institutes of Health Guidelines and 90 
regulations for care and use of test animals from Facultad de Ciencias Exactas y Naturales 91 
(Buenos Aires, Argentina, CD 140/00).  92 
 Results shown in Fig. 1a (white bars) demonstrate that reduced levels of TNF-α could be 93 
detected at day 1 p.i. for syn14-1 and syn 17-2. This low values were similar to those 94 
observed in uninfected animals (1023,48 pg/ml).  In contrast , at day 3 p.i. the level of 95 
TNF-α for both syn variants was increased, while the parental strain showed a diminution 96 
on TNF-α production (Figure 1a, grey bars). When IL-6 levels were analyzed, we found 97 
that day 1 p.i. syn14-1 values showed an increase in IL-6 production while syn17-2 showed 98 
a marked reduction in comparison with HSV-1 F, resembling the value of negative control 99 
(28,31 pg/ml) (Figure 1b, white bars). However, at day 3 p.i. no significant differences 100 
were observed for IL-6 levels in infected mice either with HSV-1 F or syn variants (Figure 101 
1b, grey bars). The differential levels in cytokine production observed for syn variants 102 
could be due to an over-expression of inhibitory cytokines. To test this possibility, our next 103 
approach was to evaluate the production of IL-10, one of the major antiinflammatory 104 
cytokines. As shown in Figure 1c, levels of IL-10 for syn14-1 and syn17-2 were lower at 1 105 
day p.i. (white bars) similar of control without infected (1157,53 pg/ml), and increased at 3 106 
days p.i. (grey bars) in comparison with parental virus. According to these results, the 107 
pattern of IL-10 production observed for HSV-1 F and both syn variants was coincident 108 
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with the course of induction of TNF-α, suggesting that reduction of TNF-α observed 1 day 109 
p.i was not due to an overproduction of IL-10. The proinflammatory cytokine IL-6 would 110 
be also regulated by IL-10 [9], however the induction of this cytokine inhibitor would not 111 
seem to explain completely the level of IL-6 observed at least for syn 14-1 variant.    112 
With the aim to evaluate the correlation of cytokines pattern with virus replication, virus 113 
titer was quantified in lung of infected mice. As can be seen in Figure 1d, at day 1 p.i., viral 114 
titers for syn14-1 and syn17-2 were 10 and 113-fold higher, respectively, than those 115 
registered for mice infected with HSV-1 F. At day 3 p.i., virus titers for syn variants as well 116 
as for the parental strain were negligible.  117 
These results suggest that intranasally inoculated syn variants would be able to modulate 118 
differentially the immune response in association with a higher replication in lungs of 119 
infected mice. At the same time, this modulation could explain the high mortality 120 
previously described for mice intranasally infected with syn14-1 and syn17-2 [12]. 121 
Therefore, it may be speculated that the increased replication of syn variants might 122 
contribute to their pathogenic phenotypes.  123 
Considering that alveolar macrophages constitute the main cell population present in the 124 
BAL fluid, we decided to analyze whether infection with HSV-1 F and syn variants 125 
affected cytokine release in an in vitro model employing the murine macrophagic cell line 126 
RAW 264.7.  For this purpose, cells were infected with HSV-1 F, syn14-1 and syn17-2 and 127 
at different times p.i., supernatants and cells monolayers were harvested and TNF-α and IL-128 
6 were determined by ELISA and RT-PCR, respectively. Cells stimulated with LPS 129 
(1.5µg/ml) were used as positive control. For PCR analysis, cell monolayers were lysed in 130 
Trizol (Invitrogen) and total RNA was isolated according to manufacturer’s instructions. 131 
cDNA was amplified with an initial incubation at 94°C during 10 min followed by 35 132 
cycles of 1 min at 94°C, 1 min at 60°C and 1 min at 72°C and a final incubation of 10 min 133 
at 72°C. β-actin was used as an internal control. As can be seen in Fig. 2a, the levels of the 134 
proinflammatory cytokines TNF-α and IL-6 were markedly reduced in cells infected with 135 
syn14-1 and syn17-2, in contrast to those observed for HSV-1 F. In fact, the concentration 136 
of both cytokines diminished by 84 to100 % for the syn variants with respect to HSV-1 F 137 
for every tested time. Furthermore, results obtained by RT-PCR correlated with those 138 
obtained by ELISA since low levels of IL-6 and TNF-α mRNAs were also detected for the 139 
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syn variants (Fig. 2b) indicating that the transcription of these cytokines genes would not be 140 
affected. Similar results were obtained using intraperitoneal macrophages harvested from 141 
BALB/c mice (data not shown). The lower levels of cytokines observed by day 1 p.i. in 142 
lung of mice infected intranasally with the syn 17-2 correlated with the results obtained 143 
with macrophages in vitro whereas those observed for syn 14-1 did not. These results 144 
suggest that the interaction between syn 14-1 and macrophages would not be the only factor 145 
responsible for the up regulation of IL-6 as seen in vivo.  146 
Taken into account that syn variants induced an altered profile of cytokines and that 147 
glycoprotein D (gD) has been pointed out as an inducer of TNF-α [7, 18] and IL-6 [19] 148 
during HSV-1 infection the sequence of this glycoprotein was analyzed. Results showed 149 
that both syn variants presented a point mutation in gD in comparison to parental virus. For 150 
syn14-1, the point mutation G889A induces a change D272N in the ectodomain of the 151 
mature form gD. In the case of syn17-2, the point mutation G1119T induces a change 152 
K348N in the cytoplasmic tail of the mature glycoprotein. Both mutations have not been 153 
previously reported and would not be present within the four functional regions of gD 154 
previously described [20].  155 
As mentioned above, NK cells activity is also crucial for innate defenses. It has been 156 
demonstrated that NK cells are recruited to the airways early after HSV-1 infection 157 
restricting the early virus replication in the lung [21]. Moreover, Nandakumar et al., 158 
reported that NK cells activation by the virus contribute to the initial reduction in viral load 159 
enhancing the stimulatory ability of the dendritic cells by enabling effective antigen 160 
processing and presentation [22]. In order to study the proportion of NK cells and 161 
monocytes in lung tissue of mice infected with syn variants, eight-week-old BALB/c mice 162 
were infected intranasally with 106 PFU of HSV-1 F strain, syn14-1 or syn17-2 and lungs 163 
were dissected for flow cytometric analysis. The marker NK 1.1 was used to detect NK 164 
cells (APC Mouse Anti-Mouse NK-1.1, APC Mouse IgG2a κ, Isotype control); however, 165 
the antigen is also a marker for specialized population of T lymphocytes (NK-T cells); and 166 
CD11b was used to detect  monocytes (FITC RAT Anti-Mouse CD11b, FITC Rat IgG2b, κ 167 
Isotype Control) (BD Pharmingen). As can be seen in Fig. 3 (white bars) no differences 168 
were observed in the percentage of monocytes present in lungs of mice infected with HSV-169 
1 F and syn variants, either at 3 or 5 days p.i. The number of NK cells at 3 days p.i. was 170 
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similar for the three viruses (Fig. 3, grey bars), however, at 5 days p.i lower percentages of 171 
NK cells were observed for both HSV-1 F and syn17-2. Syn14-1 showed a significant 172 
increase in NK cells  in comparison with mock infected mice (Fig. 3, grey bars). In order to 173 
address activation state of infiltrated cells, a combination of anti-NK 1.1 and anti-CD28 174 
(PE Hamster Anti-mouse CD28, PE Hamster IgG2, λ1 Isotype Control, BD Pharmingen) 175 
antibodies were used to identify double positive cells as activated NK cells (NK+). As 176 
shown in Table 1, lungs of mice infected with HSV-1 F showed a similar percentage of 177 
NK+ cells at 3 and 5 days p.i. In contrast, more than 90% of NK were activated in lungs 178 
infected with syn14-1 both at 3 days p.i. and 5 days p.i. (near 65%). Finally, in lungs of 179 
mice infected with syn17-2 similar results to HSV-1 F were obtained at day 3 p.i. (71.9%), 180 
while at 5 days p.i. the percentage decreased. These results are in accordance with previous 181 
histopathological studies, in which infiltration of leukocytes was detected at day 5 p.i. in 182 
lungs of mice infected with syn14-1 [12]. On the contrary, for syn17-2 the lower levels of 183 
activated NK cells could be associated with the thickening of alveolar walls and the loss of 184 
morphology as previously reported [12]. Reading et al. demonstrated that cytotoxicity of 185 
lung NK cells is influenced by both NK number and their activation state [21]. Therefore, 186 
the severe effect observed in infections carried out with syn17-2 might be associated to the 187 
reduced levels of activated NK. 188 
To summarize, the results presented in this paper suggest that syn variants have developed 189 
a strategy to delay the activation of macrophages and hence the release of proinflammatory 190 
cytokines. Thus, syn variants of HSV-1 could replicate and generate disease. In agreement 191 
with this hypothesis, the lower levels of mRNAs cytokines observed in in vitro 192 
experiments, would explain the early reduction of proinflamatory cytokines obtained for 193 
syn variants. Mogensen et al. reported that HSV-1 down regulates the production of several 194 
proinflammatory cytokines in a number of different cell types by mediating instability of 195 
proinflammatory cytokine mRNAs [4]. In this way, although alterations of gD in syn 196 
variants were detected in non-functional regions, it cannot be discarded that these 197 
modifications could be responsible, at least in part, for the altered proinflamatory cytokines 198 
pattern observed for syn variants. Nevertheless, it is important to note that the two variants 199 
proved to be avirulent when inoculated by intrvaginal route whereas both killed all 200 
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intranasally inoculated animals [12]. Therefore, the immune response at genital mucosa 201 
might be triggered in a different way comparing to the airway mucosa.   202 
Clearence of HSV-1 infection requires a tightly coordinated interaction between innate and 203 
adaptive response. NK cells are the major cell type recruited to the airways early after 204 
HSV-1 infection [21], rapidly activated as demonstrated by the up-regulation of cytotoxic 205 
capacity and production of IFN-γ. Our results showed that although similar numbers of NK 206 
cells were detected at 3 days p.i. in lungs of mice inoculated with syn variants and parental 207 
virus, the level of activation was higher for NK cells isolated from animals infected with 208 
the syn variants. On the other hand, augmented levels of proinflamatory cytokines were 209 
also detected at 3 days p.i. for syn variants. It is important to consider that infectious virus 210 
could not be recorded from lungs of either HSV-1 or syn variants infected animals at this 211 
time. In this regard, it is tempting to speculate that NK cells are able to control viral 212 
replication but they are not required for an effective viral clearance. However, T cells in 213 
lungs play an important role in lowering viral loads. In fact, Adler et al. reported that mice 214 
deficient in NK and T cells were not able to survive after an intranasal infection, whereas 215 
mice only lacking T cells could survive [23]. In this line, the differential NK infiltration 216 
and/or activation observed for syn variants at 5 days p.i. would not be related to viral 217 
clearance but instead may be responsible for the injury observed in lungs of mice infected 218 
with the variants.  219 
The ability of HSV to productively infect a wide range of hosts and cell types suggests that 220 
HSV has evolved to gain usage of alternative receptors and pathways to facilitate entry into 221 
multiple cell types [24]. Regardless of entry receptors or pathways utilized, HSV entry into 222 
host cell has common features among various routes of virus entry, including HSV fusion 223 
with the plasma membrane of the host cell. This indicates that HSV might recognize 224 
structural features of receptors that are conserved among various cell types. On this regard, 225 
it is tempting to speculate that the selective process exerted by carrageenans on HSV might 226 
generate viruses that retain their ability to infect a wide variety of cells and compensate a 227 
putative disadvantage at the stage of entrance with mutations at the level of TK and/or 228 
DNA pol genes [12, 25]. The panorama in vivo should contemplate also compensating 229 
mutations that would confer the virus the ability to evade the immune response. 230 
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In conclusion, our data provide evidence that the modulation of IL-6 and TNF-α seen in 231 
vitro as well as in vivo suggests that HSV-1 targets the proinflammatory host response as a 232 
mean of immune evasion. Results obtained in the present study are useful to understand the 233 
factors defining HSV-1 virulence in the respiratory tract of mice. Moreover, HSV-1 234 
variants constitute a valuable tool to understand the immune systems and to investigate the 235 
contribution of specific components of mucosal immunity. 236 
237 
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Figure 1. Cytokines release and viral replication in mice intranasally infected.  Ten 314 
(five for each time)  female BALB/c mice were infected intranasally with 1x106 UFP of 315 
HSV-1 F, syn14-1 and syn17-2. At 1 and 3 days p.i. three mice per group were sacrificed 316 
and BALs were performed for quantification of (a) TNF-α, (b) IL-6 and (c) IL-10 by 317 
ELISA. d) Viral titres were determined by plaque assay in homogenates of lungs from the 318 
other two mice of the group. * denotes a p-value < 0.05; ** denotes a p-value <0.05; # 319 
denotes a p-value <0.05.  320 
 321 
Figure 2.  Cytokine analysis in an in vitro model. RAW 264.7 murine macrophage cells 322 
were infected with HSV-1 F, syn14-1 and syn17-2 at a MOI of 10 PFU/cell. At different 323 
times p.i. supernatants and cell monolayers were harvested and IL-6 and TNF-α expression 324 
was evaluated by ELISA (a) and mRNAs synthesis of this cytokines was evaluated by RT-325 
PCR assay (b). Band intensity was measured by using ImageJ program, and expressed as 326 
fold changing of the ratio between the respective cytokine and β-actin. The data shown are 327 
mean ± SD of two independent experiments. cc: cell control. 328 
 329 
Figure 3. Cell influx in lungs of infected mice. Five Eight-week-old BALB/c mice per 330 
group were infected intranasally with 1x106 UFP of HSV-1 F, syn14-1 and syn17-2. At 3 331 
and 5 days p.i. lungs were harvested. (a) Cell influx was analyzed by flow cytometry and 332 
classified as monocytes (CD11b+) and NK cells (NK 1.1+). Histograms represent NK cells  333 
Isotype (grey), Mock (dashed line) and syn14-1 infection (solid line). No significant 334 
differences were detected with respect to control cells in the case of HSV-1 F and syn 17-2 335 
histograms (data not shown) (b) Activated NK cells were classified as NK 1.1+/CD28+. The 336 
data shown are mean ± SD of two independent experiments. * denotes a p-value < 0.05; ** 337 
denotes a p-value <0.05. 338 
339 
Table 1. Activated NK cells in lungs of infected mice. Five Eight-week-old BALB/c mice 340 
per group were infected intranasally with 1x106 UFP of HSV-1 F, syn14-1 and syn17-2. At 341 
3 and 5 days p.i. lungs were harvested. Activated NK cells were classified as NK 342 
1.1+/CD28+.343 
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Glossary 344 
Carrageenans: are a family of linear sulfated polysaccharides that are extracted from 345 
red seaweeds. They are widely used in the food industry, for their gelling, thickening and 346 
stabilizing properties.  347 
Selective pressure: It is a mutation-selective process used to obtain the variants. It consists 348 
of serial passages of virus in vitro in the presence of carrageenans. 349 
Variants: mutants of virus obtained under selective pressure.  350 
Cytokine: A small protein released by cells that has a specific effect on the interactions 351 
between cells, on communications between cells or on the behavior of cells. The cytokines 352 
includes the interleukins (as IL-6), lymphokines and cell signal molecules, such 353 
as tumor necrosis factor (TNF) and the interferons, which trigger inflammation and respond 354 
to infections. They are key molecules in modulating the immne response. 355 
Syncytial: It is a multinucleate cell which can result from multiple cell fusions of 356 
uninucleated cells. 357 
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Virus 3 days p.i. (% cells ± SD) 
5 days p.i. 
(% cells ± SD) 
HSV-1 F 65.4 ± 1.9 70.6 ± 2.4 
syn14-1 91.6 ± 3.6 95.0 ± 3.7 
syn17-2 71.9 ± 2.1 43.9 ± 1.3 
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Highlights 
 
• HSV-1 syn variants arise during in vitro serial passages with carrageenans. 
• The pathology of HSV-1 syn variants depends on modulation of the innate immune 
response activation. 
• Low level of TNF-α is not due to an overproduction of antiinflammatory cytokine . 
• The virulence of HSV-1 syn variants by intranasal route correlates with an enhanced 
replication. 
 
